113 results
DRS
EX-10.11
ADAP
Adaptimmune Therapeutics Plc
5 Feb 15
Draft registration statement
12:00am
the prior written consent of Adaptimmune;
2.1.3 ensure that no person gets access to such Confidential Information from it, its officers, employees … of Immunocore;
2.2.3 ensure that no person gets access to such Confidential Information from it, its officers, employees or agents unless authorised to do so
DRS
EX-10.8
ADAP
Adaptimmune Therapeutics Plc
5 Feb 15
Draft registration statement
12:00am
, to any person without the prior written consent of Adaptimmune;
4.3.3 ensure that no person gets access to such Confidential Information from it, its … written consent of Immunocore;
4.4.3 ensure that no person gets access to such Confidential Information from it, its officers, employees or agents
DRS
EX-10.9
ADAP
Adaptimmune Therapeutics Plc
5 Feb 15
Draft registration statement
12:00am
or in part, to any person without the prior written consent of Adaptimmune;
4.3.3 ensure that no person gets access to such Confidential Information from … ), in whole or in part, to any person without the prior written consent of Immunocore;
4.4.3 ensure that no person gets access to such Confidential
8-K
EX-99.1
xwp2z pg1mlksm
20 Nov 20
Regulation FD Disclosure
7:36am
20-F
EX-4.8
bq809x4z7ehyqerta
13 Oct 15
Annual report (foreign)
12:00am
20-F
EX-4.9
j6zqmvuurmy mtg
13 Oct 15
Annual report (foreign)
12:00am
20-F
EX-4.11
a57 e9jltn
13 Oct 15
Annual report (foreign)
12:00am
20-F
EX-4.13
0u3 m2j0un
13 Oct 15
Annual report (foreign)
12:00am
8-K
EX-99.2
untd gwrspkdcy
10 Apr 17
Adaptimmune Therapeutics plc Announces Closing of $42 Million Registered Direct Offering
12:00am
20-F
EX-4.12
8xjw3xzi
13 Oct 15
Annual report (foreign)
12:00am
20-F
EX-4.10
sarfyat356
13 Oct 15
Annual report (foreign)
12:00am
8-K
EX-99.1
l9ckbt
6 Aug 20
Adaptimmune Reports Q2 Financial Results and Business Update
7:37am
10-Q/A
EX-10.11
kg1k i9mm
6 Apr 17
Quarterly report (amended)
12:00am